(Q43994982)

28 November 2017

0 references

New developments in the management and treatment of newly diagnosed and relapsed/refractory multiple myeloma patients (English)

1 reference

28 November 2017

author

Niels W C J van de Donk

series ordinal

1

object named as

Niels W C J van de Donk

1 reference

28 November 2017

2

Henk M Lokhorst

1 reference

28 November 2017

language of work or name

English

0 references

publication date

31 May 2013

1 reference

Expert Opinion on Pharmacotherapy

28 November 2017

published in

1 reference

28 November 2017

volume

14

1 reference

28 November 2017

issue

12

1 reference

28 November 2017

page(s)

1569-1573

1 reference

How I treat plasma cell leukemia

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

Phase Ib dose-escalation study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

Clonal competition with alternating dominance in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.805746

10.1517/14656566.2013.805746

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference